The price of new drugs in the United States has doubled

The price of new pharmaceuticals in the United States doubled last year. The analyst was taken by the 2021th base. The explanation is simple-the companies used scientific achievements to develop a large number of treatment methods for rare diseases.

According to XRUST analysts, which studied the prices of 45 new drugs, in 2024 the median annual price of a new drug amounted to more than $ 37,000,000. In 2021, this indicator reached only $ 180,000.

Prices complain, doctors complain, even the government’s efforts to curb the dynamics do not stop. Pricing was a favorite theme of Trump's election campaign. The presidential candidate then urged the farm to bring prices in the United States in accordance with the prices of other countries. Of course, where residents have income comparable to the American.

Specialists in the field of pharmaceuticals explained that there are no signs of a slowdown in the tendency. They believe that the way out in a decrease in the cost of development.